Cortellis Competitive Intelligence
Make critical portfolio decisions backed by comprehensive pipeline and pharma competitive intelligence
Never miss a critical signal with competitive intelligence in healthcare and biopharma
Monitor the competitive landscape, validate investments and strategically prioritize your portfolio so you can focus on maximizing ROI and improving patient outcomes.
Make data-driven decisions with speed and certainty with pharma competitive intelligence solutions
Get the full picture
Access the broadest and deepest source of pipeline and competitor intel, covering over 3,000 diseases - including rare diseases – and all geographies.
Capture every move, from the outset
With more early phase data than anywhere else, you can identify new competitor programs sooner, or find and invest in early-stage assets before your competitors do.
Find answers within seconds
More than 20 granular filters allow you to zero in to the data you need to answer specific questions about your drug, therapy area or target of interest.
Inform your strategy with a single source of truth using competitive intelligence pharma databases
Make data-driven decisions
Predict drug phase shifts and success probabilities across the U.S., Europe and Asia with Drug Timeline & Success Rates. Validate your assumptions with tailored predictions based on the latest information
Forecast with confidence
Benchmark your forecasts using a unique combination of thousands of drug consensus forecasts coupled with proprietary Cortellis drug sales analysis. Gain granularity by exploring forecasts by region, therapy, drug brand, or drug group or subgroups.
Access integrated insights
A seamless gateway to regulatory, drug discovery, clinical trial, deals, and generics intelligence, with direct links and single sign-on making it easy to find related content. Our gold-standard data is also available via APIs or data feeds.
Rely on trusted and timely drug information with pharma competitive intelligence solutions
Cortellis simplifies competitive intelligence, allowing you to focus on developing your strategy — without fear of being blindsided.
Differentiate your asset
Assess your market — whether by MoA, disease/therapeutic area, or technology — and understand competitor positioning using SWOT analyses.
Get critical alerts in your inbox
Review high-priority insights that Cortellis automatically surfaces to your inbox, tailored for the topics and frequency that works for you.
Pinpoint the data that matters most
Over 20 granular filters allow you to zero in to the specific answers you need about your drug, therapy area or target of interest.
Our comprehensive coverage, by the numbers
100k+
316k+
~3k
1450+
3000+
6.9m+
Resources
Frequently asked questions
Answers to common questions about Cortellis and our competitive intelligence solutions
Cortellis Competitive Intelligence is an end‑to‑end pharma competitive intelligence platform that helps life sciences organizations make confident portfolio and business development decisions across global markets.
Cortellis Competitive Intelligence provides the broadest and deepest biopharma pipeline intelligence, covering 3,000+ diseases – including rare and niche indications – across global geographies. Unlike other tools, Cortellis offers more early‑phase data, enabling users to identify competitor programs sooner and act on early‑stage partnering or investment opportunities. Integrated access to Cortellis regulatory, clinical, patent, deal and generics data creates a single source of truth for competitive intelligence.
Cortellis Competitive Intelligence is trusted by leading life sciences organizations, including Top 50 global pharma companies, emerging biotech firms, and specialized pharmaceutical competitive intelligence teams, as well as investment professionals.
Cortellis Competitive Intelligence is ideal for professionals in portfolio strategy, licensing and business development, competitive intelligence, and R&D investment planning who need accurate, timely insights to guide high‑stakes decisions. It supports users across commercial, medical and R&D functions who rely on biopharma competitive intelligence to track competitors, prioritize pipelines and validate market opportunities.
Leading life sciences organizations choose Cortellis Competitive Intelligence because it delivers broader, deeper pharma competitive intelligence and more advanced, proven analytics.
Compared to other competitive intelligence solutions, Cortellis Competitive Intelligence offers:
- Unmatched early pipeline coverage for discovery and preclinical programs.
- Proprietary predictive analytics like Drug Timeline & Success Rates, proven to be 35%+ more accurate than standard industry benchmarks.
Integrated insights across pipeline, regulatory, clinical, deal, and patent data in one platformGranular filtering that enable faster, more precise analysis
Cortellis Competitive Intelligence supports high-impact decisions such as prioritizing therapeutic areas, evaluating in-licensing or partnering opportunities, and identifying high potential early stage assets. It also helps teams plan for competitor launches, optimize portfolio and resource allocation, and build more accurate forecasts by grounding strategy in comprehensive, curated pipeline, clinical, regulatory, deal, and patent intelligence.
Cortellis Competitive Intelligence includes advanced predictive analytics through our patented Drug Timeline & Success Rates (DT&SR) tool, which uses a proprietary machine learning‑driven algorithm built on more than 22 years of curated Cortellis data.
The DT&SR tool forecasts drug development timelines and likely launch dates, as well as phase‑by‑phase probabilities of success for individual assets. It also supports competitive benchmarking for major milestones with region‑specific predictions across markets such as the US, EU, Japan, China, Singapore and South Korea. Predictions automatically refresh with the latest insights to reflect real-time shifts in the development landscape, enabling proactive scenario planning for asset strategy, competitive tracking, and partnership valuations.
Cortellis Competitive Intelligence comprehensive pharma competitive intelligence data that is expertly curated and harmonized into a single, unified platform, giving life sciences teams a current, consistent view of the market.
Cortellis Competitive Intelligence brings together drug and company intelligence, clinical trial outcomes, patent filings, deal activity, proprietary drug sales and forecast data, and more in one solution for end‑to‑end competitive analysis. Data is continuously updated from global sources so users have the latest insights for biopharma competitive intelligence, due diligence, licensing evaluations, and portfolio strategy decisions.
Yes, Cortellis Competitive Intelligence data can be delivered as bulk data via feeds or APIs so you can power internal analytics, dashboards and enterprise applications with trusted pharma competitive intelligence.
Follow us
Contact us
